EMNAR PHARMA PRIVATE LTD

Overview

EMNAR PHARMA PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 37 active FDA Type II Drug Master Files, covering (S)-(+)-2-AMINOBUTYRAMIDE HYDROCHLORIDE; 2-(1-(CARBAMOYLMETHYL)CYCLOHEXYL)ACETIC ACID(CAM)/GABAPENTIN INTERMEDIATE; ACOTIAMIDE HYDROCHLORIDE HYDRATE; APIXABAN; BUPROPION HYDROCHLORIDE; CALCIUM CARBONATE.

API / Drug Master Files

EMNAR PHARMA PRIVATE LTD holds 37 active (37 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LINEZOLIDActive2026-03-31
• DOLUTEGRAVIR SODIUMActive2026-03-27
• VALPROIC ACIDActive2026-03-04
• PRUCALOPRIDE SUCCINATEActive2026-02-12
• COPPER SULFATE PENTAHYDRATEActive2026-01-22
• MAGNESIUM SULFATE HEPTAHYDRATEActive2025-12-18
• SODIUM ACETATEActive2025-12-01
• POTASSIUM SULFATEActive2025-10-17
• TAFAMIDIS INTERMEDIATEActive2025-07-13
• LAMIVUDINEActive2025-06-27
• CAPECITABINEActive2025-05-10
• APIXABANActive2025-04-01
• SODIUM VALPROATEActive2025-03-29
• CALCIUM CARBONATEActive2025-03-28
• SODIUM CHLORIDEActive2025-03-05

Showing 15 of 37 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EMNAR PHARMA PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.